Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 May-Jun;88(3):375-380.
doi: 10.1016/j.bjorl.2020.06.013. Epub 2020 Aug 6.

Analysis of prognostic factors for Tis-2N0M0 early glottic cancer with different treatment methods

Guanyu Wang  1 , Guodong Li  2 , Jianjun Wu  1 , Penghui Song  3
Affiliations

Analysis of prognostic factors for Tis-2N0M0 early glottic cancer with different treatment methods

Guanyu Wang et al. Braz J Otorhinolaryngol. 2022 May-Jun.

Abstract

Introduction: In many regions, laryngeal carcinoma is a common upper respiratory tract cancer, most commonly involving the glottic region. The treatment of early glottic cancer includes radiotherapy, open surgery and laryngeal laser microsurgery. However, the preferred treatment for early glottic cancer is still controversial.

Objectives: To study the factors affecting the 5-year survival rate of Tis-2N0M0 early glottis cancer and to demonstrate the oncological safety of different treatments.

Methods: 144 patients with early glottic cancer were analyzed retrospectively. All patients were clinically node negative. 53 patients underwent open surgery, transoral CO2 laser microsurgery in 46 cases and radiotherapy in 45 cases. The patients were followed up for 26 - 84 months, with an average follow-up period of 62.9 months.

Results: The 5-year overall survival was 82.6%. The 5 year survival rates of open surgery, laser microsurgery and radiotherapy were 83.0%, 82.6% and 82.2%, respectively. There was no significant difference in 5-year survival rate among the three treatments (p = 0.987). In multivariate analysis, age, T-stage, pathological grading, and anterior commissure involvement were important prognostic factors for early glottic cancer.

Conclusion: There was no significant difference in 5 year survival rate among patients treated by either radiotherapy, laser microsurgery or open surgery for early glottic cancer. We urge more attention to the age, T-stage, pathological grade, and anterior commissure involvement of the patients.

Keywords: 5-year survival rate; Glottic cancer; Laser microsurgery; Prognostic factors; Radiotherapy.

PubMed Disclaimer

Figures

Fig. 1
Figure 1
Comparison of 5-year survival rate of three treatments (p =  0.987).
Fig. 2
Figure 2
Comparison of 5-year survival rate by age group (p =  0.022).
Fig. 3
Figure 3
Comparison of 5-year survival rates by gender (p =  0.970).
Fig. 4
Figure 4
Comparison of 5-year survival rate according to T-stage (p =  0.005).
Fig. 5
Figure 5
Comparison of 5-year survival rate according to pathological grade (p <  0.001).
Fig. 6
Figure 6
Comparison of 5-year survival rate according to anterior commissure involvement (p <  0.001).
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Ferri E., Armato E. Diode laser microsurgery for treatment of Tis and T1 glottic carcinomas. Am J Otolaryngol. 2008;29:101–105. - PubMed
    1. Ambrosch P., Fazel A. Functional organ preservation in laryngeal and hypopharyngeal cancer. GMS Curr Top Otorhinolaryngol Head Neck Surg. 2011;10 c2. - PMC - PubMed
    1. Mendenhall W.M., Amdur R.J., Morris C.G., Hinerman R.W. T1-T2N0 squamous cell carcinoma of the glottic larynx treated with radiation therapy. J. Clin Oncol. 2001;19:4029–4036. - PubMed
    1. Chera B.S., Amdur R.J., Morris C.G., Kirwan J.M., Mendenhall W.M. T1N0 to T2N0 squamous cell carcinoma of the glottic larynx treated with definitive radiotherapy. Int J Radiat Oncol Biol Phys. 2010;78:461–466. - PubMed
    1. Peretti G., Piazza C., Cocco D., De Benedetto L., Del B.F., Redaelli D.Z.L., et al. Transoral CO(2) laser treatment for T(is)-T(3) glottic cancer: the University of Brescia experience on 595 patients. Head Neck. 2010;32:977–983. - PubMed